Sarah Dewilde

1.7k total citations
52 papers, 1.2k citations indexed

About

Sarah Dewilde is a scholar working on Economics and Econometrics, Neurology and Epidemiology. According to data from OpenAlex, Sarah Dewilde has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 11 papers in Neurology and 11 papers in Epidemiology. Recurrent topics in Sarah Dewilde's work include Health Systems, Economic Evaluations, Quality of Life (19 papers), Myasthenia Gravis and Thymoma (11 papers) and Acute Ischemic Stroke Management (10 papers). Sarah Dewilde is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (19 papers), Myasthenia Gravis and Thymoma (11 papers) and Acute Ischemic Stroke Management (10 papers). Sarah Dewilde collaborates with scholars based in Belgium, United Kingdom and Netherlands. Sarah Dewilde's co-authors include Andrew Lloyd, Beenish Nafees, Jessamy Watkins, María Gabriela Lorenzo, Narayan Rajan, Magnus Tambour, Thomas Sandström, Vincent Thijs, Mathieu F. Janssen and Simon Noble and has published in prestigious journals such as Blood, Journal of Clinical Epidemiology and British Journal of Cancer.

In The Last Decade

Sarah Dewilde

49 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Dewilde Belgium 16 405 366 355 155 138 52 1.2k
Florian Scotté France 27 1.1k 2.6× 459 1.3× 97 0.3× 138 0.9× 116 0.8× 131 2.0k
Bram Ramaekers Netherlands 20 296 0.7× 506 1.4× 337 0.9× 125 0.8× 189 1.4× 95 1.7k
Sabrina Trippoli Italy 17 213 0.5× 133 0.4× 218 0.6× 85 0.5× 83 0.6× 99 932
Maureen P. Neary United States 25 717 1.8× 538 1.5× 405 1.1× 535 3.5× 96 0.7× 111 2.4k
María Eberg Canada 14 341 0.8× 339 0.9× 70 0.2× 69 0.4× 175 1.3× 32 1.0k
Francis Vekeman United States 22 177 0.4× 233 0.6× 103 0.3× 133 0.9× 59 0.4× 89 1.3k
Ralph Crott Belgium 20 233 0.6× 270 0.7× 273 0.8× 99 0.6× 54 0.4× 62 1.2k
Ahmet Akyol Türkiye 22 353 0.9× 222 0.6× 113 0.3× 76 0.5× 356 2.6× 95 1.4k
Jonas Lundkvist Sweden 20 181 0.4× 528 1.4× 211 0.6× 80 0.5× 298 2.2× 49 1.5k
Vasily Giannakeas Canada 22 553 1.4× 191 0.5× 93 0.3× 144 0.9× 53 0.4× 59 1.5k

Countries citing papers authored by Sarah Dewilde

Since Specialization
Citations

This map shows the geographic impact of Sarah Dewilde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Dewilde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Dewilde more than expected).

Fields of papers citing papers by Sarah Dewilde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Dewilde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Dewilde. The network helps show where Sarah Dewilde may publish in the future.

Co-authorship network of co-authors of Sarah Dewilde

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Dewilde. A scholar is included among the top collaborators of Sarah Dewilde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Dewilde. Sarah Dewilde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dewilde, Sarah, Pierre Boulanger, R. C. Pardo, et al.. (2025). Caregiving burden among caregivers of people with myasthenia gravis. Orphanet Journal of Rare Diseases. 20(1). 311–311.
2.
Dewilde, Sarah, et al.. (2025). A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity. Frontiers in Public Health. 13. 1538789–1538789.
3.
Dewilde, Sarah, Alison Griffiths, Cynthia Z. Qi, et al.. (2024). Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis. Journal of the Neurological Sciences. 466. 123264–123264. 7 indexed citations
4.
Janssen, Mathieu F., Sarah Dewilde, Gil I. Wolfe, Srikanth Muppidi, & Glenn Phillips. (2024). Psychometric properties of MG-ADL items and MG-ADL score: An assessment of distributional characteristics, validity and factor structure in two large datasets. Journal of the Neurological Sciences. 463. 123135–123135.
5.
Dewilde, Sarah, Mathieu F. Janssen, Brendan Mulhern, & Fanni Rencz. (2024). MSR129 Psychometric Properties of Six EQ-5D-5L Bolt-Ons in a Rare Disease Population: A Multinational, Longitudinal Study. Value in Health. 27(12). S463–S463. 1 indexed citations
7.
Dewilde, Sarah, Mathieu F. Janssen, Fiammetta Vanoli, et al.. (2023). Concordance between patient‐ and physician‐reported Myasthenia Gravis Activities of Daily Living (MG‐ADL) scores. Muscle & Nerve. 68(1). 65–72. 5 indexed citations
9.
Dewilde, Sarah, Malou Janssen, Kristl G. Claeys, et al.. (2022). POSC375 Digital Data Collection to Measure the Impact of Myasthenia Gravis on Patients' Quality of Life in the Real World: Report at Baseline. Value in Health. 25(1). S246–S246. 1 indexed citations
11.
Berrih‐Aknin, Sonia, Kristl G. Claeys, Nancy Law, et al.. (2021). Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG). BMJ Open. 11(7). e048198–e048198. 15 indexed citations
13.
Dewilde, Sarah, Bas Janssen, Andrew Lloyd, & Koonal Shah. (2020). PNS214 Exploration of the Reasons Why Health State Valuation Differs for Children Compared to Adults: A MIXED Methods Approach. Value in Health. 23. S677–S677. 7 indexed citations
14.
Dewilde, Sarah, Lieven Annemans, André Peeters, et al.. (2018). The relationship between Home-time, quality of life and costs after ischemic stroke: the impact of the need for mobility aids, home and car modifications on Home-time. Disability and Rehabilitation. 42(3). 419–425. 15 indexed citations
15.
Dewilde, Sarah, et al.. (2015). Quality Of Life Of Patients Experiencing Cancer-Associated Thrombosis. Value in Health. 18(7). A397–A398. 8 indexed citations
16.
Dewilde, Sarah, Lieven Annemans, & Vincent Thijs. (2015). Analysis Of Primary And Secondary Apr-Drg Codes Of An Ischemic Stroke Admission. Value in Health. 18(7). A400–A400. 1 indexed citations
17.
Dewilde, Sarah, Vincent Thijs, Lieven Annemans, & André Peeters. (2014). Quality of Life Decrements after Stroke. Value in Health. 17(7). A331–A331. 4 indexed citations
18.
Lloyd, Andrew, et al.. (2011). Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: Heterogeneity in parent preferences. International Journal of Technology Assessment in Health Care. 27(3). 215–223. 16 indexed citations
19.
Lloyd, Andrew, et al.. (2007). Preferences and utilities for the symptoms of moderate to severe allergic asthma. The European Journal of Health Economics. 9(3). 275–284. 16 indexed citations
20.
Lloyd, Andrew, et al.. (2006). Health state utilities for metastatic breast cancer. British Journal of Cancer. 95(6). 683–690. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026